Cash flow Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 13/09/2024 BST			5-day change	1st Jan Change
238.70 ^USD	+0.13%		-1.80%	+3.16%

09-06	Veeva Systems: leader in cloud solutions for the life sciences industry
09-04	'Brighter Skies' Ahead for IQVIA As EPS Set to 'Reaccelerate', RBC Capital Says	MT

5ddf7.xKYXIbsSpBxL88Lk9_4ouvHpCR30XPftW98lHDauZ6A.hZBIW4wq43IynvGqhJ9645amTHG-MJCBN_JhMXnpM-G-_lRk2kjicXOCpQ

Published financial data: IQVIA HOLDINGS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	11.09B	11.36B	13.87B	14.41B	14.98B
Total Revenues	11.09B	11.36B	13.87B	14.41B	14.98B
Cost of Goods Sold, Total	7.3B	7.5B	9.23B	9.38B	9.74B
Gross Profit	3.79B	3.86B	4.64B	5.03B	5.24B
Selling General & Admin Expenses, Total	1.71B	1.76B	1.93B	2.04B	2.04B
Depreciation & Amortization - (IS)	1.2B	1.29B	1.26B	1.13B	1.12B
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	2.91B	3.05B	3.2B	3.17B	3.17B
Operating Income	875M	810M	1.45B	1.86B	2.07B
Interest Expense, Total	-447M	-416M	-375M	-416M	-672M
Interest And Investment Income	9M	6M	6M	13M	36M
Net Interest Expenses	-438M	-410M	-369M	-403M	-636M
Income (Loss) On Equity Invest.	-9M	7M	6M	-12M	-
Currency Exchange Gains (Loss)	6M	-1M	-	-	-
Other Non Operating Income (Expenses)	-39M	-5M	38M	-54M	36M
EBT, Excl. Unusual Items	395M	401M	1.12B	1.39B	1.47B
Restructuring Charges	-75M	-52M	-20M	-28M	-84M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	43M	25M	16M	-27M	20M
Asset Writedown	-	-	-	-	-
Other Unusual Items	-20M	6M	17M	15M	52M
EBT, Incl. Unusual Items	343M	380M	1.13B	1.35B	1.46B
Income Tax Expense	116M	72M	163M	260M	101M
Earnings From Continuing Operations	227M	308M	971M	1.09B	1.36B
Net Income to Company	227M	308M	971M	1.09B	1.36B
Minority Interest	-36M	-29M	-5M	-	-
Net Income - (IS)	191M	279M	966M	1.09B	1.36B
Net Income to Common Incl Extra Items	191M	279M	966M	1.09B	1.36B
Net Income to Common Excl. Extra Items	191M	279M	966M	1.09B	1.36B
Per Share Items
Net EPS - Basic	0.98	1.46	5.05	5.82	7.39
Basic EPS - Continuing Operations	0.98	1.46	5.05	5.82	7.39
Basic Weighted Average Shares Outstanding	195M	191M	191M	188M	184M
Net EPS - Diluted	0.96	1.43	4.95	5.72	7.29
Diluted EPS - Continuing Operations	0.96	1.43	4.95	5.72	7.29
Diluted Weighted Average Shares Outstanding	200M	195M	195M	191M	186M
Normalized Basic EPS	1.08	1.16	3.63	4.63	5
Normalized Diluted EPS	1.06	1.14	3.57	4.56	4.93
Supplemental Items
EBITDA	1.88B	1.83B	2.5B	2.57B	2.72B
EBITA	1.75B	1.7B	2.35B	2.41B	2.57B
EBIT	875M	810M	1.45B	1.86B	2.07B
EBITDAR	2.07B	2.04B	2.68B	2.74B	2.88B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	33.82	18.95	14.37	19.24	6.92
Current Domestic Taxes	11M	-	16M	24M	21M
Current Foreign Taxes	248M	244M	293M	358M	349M
Total Current Taxes	259M	244M	309M	382M	370M
Deferred Domestic Taxes	-109M	-161M	-106M	-94M	-236M
Deferred Foreign Taxes	-34M	-11M	-40M	-28M	-33M
Total Deferred Taxes	-143M	-172M	-146M	-122M	-269M
Normalized Net Income	211M	222M	696M	869M	919M
Non-Cash Pension Expense	-23M	-27M	-33M	-33M	-10M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	193M	209M	184M	171M	160M
Imputed Operating Lease Interest Expense	59.38M	54.96M	42.88M	44.09M	63.03M
Imputed Operating Lease Depreciation	134M	154M	141M	127M	96.97M
Stock-Based Comp., SG&A Exp. (Total)	146M	95M	170M	194M	217M
Total Stock-Based Compensation	146M	95M	170M	194M	217M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	837M	1.81B	1.37B	1.22B	1.38B
Short Term Investments	62M	88M	111M	93M	120M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	899M	1.9B	1.48B	1.31B	1.5B
Accounts Receivable, Total	2.58B	2.41B	2.55B	2.92B	3.38B
Other Receivables	56M	56M	58M	43M	32M
Total Receivables	2.64B	2.47B	2.61B	2.96B	3.41B
Prepaid Expenses	138M	159M	156M	151M	141M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	451M	563M	521M	561M	546M
Total Current Assets	4.13B	5.09B	4.76B	4.98B	5.6B
Gross Property Plant And Equipment	1.55B	1.63B	1.67B	1.7B	1.62B
Accumulated Depreciation	-597M	-673M	-765M	-840M	-803M
Net Property Plant And Equipment	954M	953M	903M	863M	819M
Long-term Investments	152M	162M	168M	162M	239M
Goodwill	12.16B	12.65B	13.3B	13.92B	14.57B
Other Intangibles, Total	5.51B	5.2B	4.94B	4.82B	4.84B
Deferred Tax Assets Long-Term	119M	114M	124M	118M	166M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	227M	386M	487M	472M	455M
Total Assets	23.25B	24.56B	24.69B	25.34B	26.68B
Liabilities
Accounts Payable, Total	575M	581M	621M	645M	709M
Accrued Expenses, Total	1.06B	1.27B	1.42B	1.49B	1.48B
Current Portion of Long-Term Debt	100M	149M	91M	152M	769M
Current Portion of Leases	153M	156M	149M	116M	107M
Current Income Taxes Payable	108M	102M	137M	161M	116M
Unearned Revenue Current, Total	1.78B	2.1B	2.71B	2.86B	3.11B
Other Current Liabilities	177M	198M	119M	152M	199M
Total Current Liabilities	3.94B	4.56B	5.24B	5.58B	6.49B
Long-Term Debt	11.58B	12.44B	12.06B	12.6B	12.96B
Long-Term Leases	396M	493M	490M	488M	451M
Pension & Other Post Retirement Benefits	213M	257M	231M	179M	214M
Deferred Tax Liability Non Current	646M	338M	410M	464M	202M
Other Non Current Liabilities	213M	198M	217M	268M	256M
Total Liabilities	16.99B	18.28B	18.65B	19.57B	20.57B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	11.05B	11.09B	10.77B	10.9B	11.02B
Retained Earnings	998M	1.28B	2.24B	3.33B	4.69B
Treasury Stock	-5.73B	-6.17B	-6.57B	-7.74B	-8.74B
Comprehensive Income and Other	-311M	-205M	-406M	-727M	-867M
Total Common Equity	6B	6B	6.04B	5.76B	6.11B
Minority Interest	260M	279M	-	-	-
Total Equity	6.26B	6.28B	6.04B	5.76B	6.11B
Total Liabilities And Equity	23.25B	24.56B	24.69B	25.34B	26.68B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	192M	191M	190M	186M	182M
ECS Total Common Shares Outstanding	192M	191M	191M	186M	182M
Book Value / Share	31.22	31.39	31.7	31.04	33.67
Tangible Book Value	-11.67B	-11.86B	-12.2B	-12.98B	-13.29B
Tangible Book Value Per Share	-60.69	-62.02	-64.02	-69.88	-73.25
Total Debt	12.22B	13.24B	12.79B	13.35B	14.28B
Net Debt	11.32B	11.34B	11.31B	12.04B	12.79B
Debt Equivalent of Unfunded Proj. Benefit Obligation	173M	244M	122M	87M	94M
Debt Equivalent Oper. Leases	1.54B	1.67B	1.47B	1.37B	1.28B
Minority Interest, Total (Incl. Fin. Div)	260M	279M	-	-	-
Equity Method Investments, Total	87M	84M	88M	94M	134M
Account Code - Inventory Valuation	3	3	3	-	-
Land - (BS)	331M	351M	376M	363M	376M
Machinery, Total	724M	804M	886M	1.01B	950M
Full Time Employees	67K	70K	79K	86K	87K
Accumulated Allowance for Doubtful Accounts (Supple)	16M	34M	33M	36M	34M
Order Backlog	19B	22.6B	24.8B	27.2B	29.7B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	191M	279M	966M	1.09B	1.36B
Depreciation & Amortization - CF	128M	134M	147M	160M	151M
Amortization of Goodwill and Intangible Assets - (CF)	878M	886M	906M	551M	499M
Depreciation & Amortization, Total	1.01B	1.02B	1.05B	711M	650M
Amortization of Deferred Charges, Total - (CF)	209M	285M	228M	434M	493M
(Gain) Loss From Sale Of Asset	1M	-	-	-10M	-
(Gain) Loss on Sale of Investments - (CF)	-43M	-25M	-16M	27M	-20M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	9M	-7M	-6M	12M	-
Stock-Based Compensation (CF)	146M	95M	170M	194M	217M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-121M	-147M	-133M	-115M	-269M
Change In Accounts Receivable	-122M	255M	-138M	-421M	-388M
Change In Accounts Payable	240M	253M	244M	427M	267M
Change in Unearned Revenues	-2M	180M	591M	31M	-29M
Change In Income Taxes	-5M	-83M	-2M	-128M	-164M
Change in Other Net Operating Assets	-92M	-146M	-15M	7M	34M
Cash from Operations	1.42B	1.96B	2.94B	2.26B	2.15B
Capital Expenditure	-582M	-616M	-640M	-674M	-649M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-588M	-177M	-1.46B	-1.32B	-876M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-25M	-1M	-10M	-25M	-83M
Other Investing Activities, Total	5M	-2M	5M	8M	5M
Cash from Investing	-1.19B	-796M	-2.1B	-2.01B	-1.6B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	4.42B	2.84B	2.76B	3.6B	6.38B
Total Debt Issued	4.42B	2.84B	2.76B	3.6B	6.38B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-3.68B	-2.5B	-2.69B	-2.66B	-5.58B
Total Debt Repaid	-3.68B	-2.5B	-2.69B	-2.66B	-5.58B
Issuance of Common Stock	11M	-	-	-	-
Repurchase of Common Stock	-949M	-447M	-406M	-1.17B	-992M
Other Financing Activities, Total	-85M	-112M	-899M	-102M	-192M
Cash from Financing	-276M	-217M	-1.24B	-329M	-382M
Foreign Exchange Rate Adjustments	-5M	31M	-52M	-75M	-4M
Net Change in Cash	-54M	977M	-448M	-150M	160M
Supplemental Items
Cash Interest Paid	421M	399M	343M	379M	-
Cash Income Tax Paid (Refund)	215M	209M	222M	255M	340M
Levered Free Cash Flow	1.01B	1.48B	1.97B	1.37B	1.35B
Unlevered Free Cash Flow	1.28B	1.72B	2.19B	1.61B	1.75B
Change In Net Working Capital	33M	-447M	-494M	202M	239M
Net Debt Issued / Repaid	747M	342M	70M	941M	802M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	2.39	2.12	3.67	4.65	4.98
Return on Total Capital	3	2.67	4.75	6.18	6.61
Return On Equity %	3.43	4.91	15.76	18.48	22.87
Return on Common Equity	3	4.65	16.04	18.48	22.87
Margin Analysis
Gross Profit Margin %	34.16	33.97	33.45	34.89	34.96
SG&A Margin	15.43	15.51	13.92	14.14	13.63
EBITDA Margin %	16.96	16.11	18.01	17.84	18.16
EBITA Margin %	15.81	14.93	16.95	16.73	17.15
EBIT Margin %	7.89	7.13	10.42	12.91	13.82
Income From Continuing Operations Margin %	2.05	2.71	7	7.57	9.06
Net Income Margin %	1.72	2.46	6.96	7.57	9.06
Net Avail. For Common Margin %	1.72	2.46	6.96	7.57	9.06
Normalized Net Income Margin	1.9	1.95	5.01	6.03	6.14
Levered Free Cash Flow Margin	9.14	13.01	14.23	9.48	8.99
Unlevered Free Cash Flow Margin	11.54	15.14	15.8	11.18	11.67
Asset Turnover
Asset Turnover	0.48	0.48	0.56